Polestar Technologies and Harvard Bioscience Partner to Provide Sensing Products to Regenerative Medicine Market
FOR IMMEDIATE RELEASE
Date: May 11, 2011
Polestar Technologies and Harvard Bioscience Partner to Provide Sensing Products to Regenerative Medicine Market
Needham Heights, MA, May 11, 2011 - Polestar Technologies, a leading provider of sensor systems for the biotechnology and
pharmaceutical (biopharma) industries and Harvard Bioscience, Inc. (NASDAQ: HBIO) a global developer, manufacturer and
marketer of tools for life science research and regenerative medicine, and have formed a partnership to bring new
biosensing technologies to the regenerative medicine and tissue engineering marketplace. Through this partnership, Harvard
Bioscience will have the right to sell Polestar Technologies' sensor systems as stand-alone products or as integrated
components of Harvard Apparatus' physiology research systems and regenerative medicine bioreactors. The partnership also
provides for the co-development of new sensors for this market.
According to "2020 Vision-A Future for Regenerative Medicine" from the US Department of Health and Human Services, the US
market for regenerative medicine products is expected to be $100 billion. Harvard Bioscience estimates the nascent market
for regenerative medicine tools could potentially grow to hundreds of millions of dollars annually. Harvard Bioscience is
committed to bringing innovative and high-quality tools and expertise to this emerging market, and this is why they chose
to partner with Polestar Technologies. Polestar Technologies has unique, patented, and accurate optical sensing products
that measure pH, O2, and CO2 (in one system), critical factors in monitoring the growth of cells and tissues.
Ron Sostek, Vice President of Business Development for the Harvard Apparatus division of Harvard Bioscience stated, "We
made a strategic decision to partner with Polestar Technologies given that they have both the expertise and the superior
sensor solutions that allow us to bring a suite of powerful new research tools to our customers." Rusty Warren, President
of the Products Division of Polestar Technologies added, "We view this relationship as a true partnership because Harvard
Apparatus is the standard for quality physiology R&D equipment and expertise, and Polestar Technologies is fast becoming
the standard sensor provider for the regenerative medicine / tissue engineering market."
About Polestar Technologies, Inc.
Founded in 1993, Polestar Technologies Inc. is a leading provider of optical monitors, sensors, and probes for lab,
industrial, and commercial applications. Polestar manufactures monitors and sensors that are the standard for accurately
measuring oxygen (O2), dissolved oxygen (DO), carbon dioxide (CO2), and pH and makes the only monitor that measures all
elements at once. The company also produces a variety of single use (disposable) sensors to service a variety of
industries with a focus on the biotechnology / pharmaceuticals (biopharma) and bioprocessing industries. In addition to
its products, Polestar has a technology consulting division and also conducts sensor research and technology development
for NIH, NASA, DARPA as well as other government agencies. Polestar's sensor products are the direct result of that
research and are used by Fortune 100 companies worldwide.
About Harvard Bioscience
Harvard Bioscience ("HBIO") is a global developer, manufacturer and marketer of a broad range of specialized products,
primarily apparatus and scientific instruments, used to advance life science research and regenerative medicine. HBIO
sells its products to thousands of researchers in over 100 countries primarily through its 850 page catalog (and various
other specialty catalogs), its website, through distributors, including GE Healthcare, Thermo Fisher Scientific and VWR,
and via our field sales organization. HBIO has sales and manufacturing operations in the United States, the United
Kingdom, Germany and Spain with additional facilities in France and Canada.
Back to News
